Axial Biotherapeutics

Last updated: March 04, 2024

David Donabedian - Cofounder, CEO
David Donabedian - Cofounder, CEO
Country: USA | Funding: $115.9M (+)

Website: https://www.axialbiotherapeutics.com/

Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and Central Nervous System to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders